Novavax
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $56,698 | $139,514 | $147,139 | $70,445 |
Gross Profit | 42,452 | 108,819 | 121,935 | 48,949 |
EBITDA | -39,869 | -543 | 28,852 | -190,969 |
EBIT | -45,987 | -3,605 | 23,727 | -197,554 |
Net Income | -53,387 | -9,491 | 17,527 | -202,379 |
Net Change In Cash | 56,698 | 139,514 | 147,139 | 70,445 |
Free Cash Flow | -74,135 | -33,693 | -41,551 | 105,787 |
Cash | 191,458 | 228,363 | 240,634 | 268,023 |
Basic Shares | 164,574 | 163,276 | 173,103 | 162,353 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,123,479 | $682,162 | $556,382 | $1,598,951 |
Gross Profit | 1,052,339 | 479,423 | 212,614 | 696,312 |
EBITDA | 492,327 | -108,044 | -487,390 | -604,713 |
EBIT | 464,714 | -156,540 | -528,615 | -633,767 |
Net Income | 440,302 | -187,499 | -545,062 | -657,939 |
Net Change In Cash | 1,123,479 | 682,162 | 556,382 | 1,598,951 |
Free Cash Flow | -250,195 | -100,320 | -772,773 | -508,922 |
Cash | 240,634 | 530,230 | 568,505 | 1,336,883 |
Basic Shares | 173,103 | 152,190 | 100,768 | 78,183 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.32 |
2026-03-31 | -$0.06 |
2025-12-31 | $0.11 |
2025-09-30 | -$0.47 |